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The impact of CGM on the duration of periods with low glucose measured in interstitial fluid is 
well known. But studies showing an impact of CGM on low blood glucose values, measured by 
POC-GM are rare. This cross-over study examines the impact of CGM on duration of periods 
spent in low interstitial glucose range (<70 mg/dl) as well as on the proportion of low blood 
glucose (BG) values measured by POC-GM (Glukometer 3000, Bio Sensor Technology, Germa-
ny) and time until detection of low BG by use of POC-GM.
41 type 1 diabetic patients (age 42.0±11.3 yrs, diabetes duration 15.3 ±10.1; A1c 8.2 ±1.4%) 
used the DEXCOM 7 Plus CGM system twice; once participants were blinded against the re-
sults and in the other study phase (Open CGM) patients received real-time glucose values and 
current glucose trends, used the CGM data to determine their insulin dose and were alerted 
if hypoglycemic or hyperglycemic glucose ranges were approached. In addition, BG was routi-
nely measured 6 times a day by POC-GM. The order of study phases was randomized. The time 
spent in a hypoglycemic glucose range (< 70 mg/dl) was reduced by open CGM from 181±125 
to 125± 89 minutes per day (p=.005). Also time spent in the euglycemic glucose range was 
increased from 946±176 to 1023±168 minutes per day (p=.003). Open CGM reduced the pro-
portion of low BG measurements by POC-GM from 10.3±7.6% to 7.4±5.8% (p=.039), whereas 
the euglycemic POC readings was increased from 68.3 ±12.1% to 73.7 ±12.1% (p=.007). The 
time until a hypoglycemic BG value was detected by POC-GM was significantly (p.028) shor-
tened by 33.1 (95% CI 3.8 -62.3) minutes. 
These results demonstrate that CGM used for insulin dosing and hypoglycemia alerts not only 
diminishes low interstitial glucose values but also reduces the proportion of low BG measured 
by POC-GM. In addition the time for the detection of a hypoglycemic episode by POC-GM was 
significantly shortened.
Table 1:   Sample Characteristics
Figure 1:  Cross-over study design
The meta-analysis from Pickup et al. (BMJ, 2011, 343, d3805) indicates that Continuous 
Glucose Monitoring (CGM) use can improve glycemic control by 0.3 HbA1c percentage 
points. Furthermore, exposure to hypoglycemia can be reduced by 23%. However, while 
the improvement of glycemia can be assessed by an external laboratory measure, the im-
provement of exposure to hypoglycemia relies on the measurement of glucose values in 
the interstitial fluid measured by the CGM systems itself. Nevertheless, measurement pre-
cision of CGM in the hypoglycemic range is less concordant with a reference method than 
measurement in eu- or hyperglycemic ranges. CGM systems are indicated for use as an 
adjunctive device to complement, not replace, information obtained from standard blood 
glucose measurements by Point Of Care Glucose Meters (POC-GM). Therefore blood glu-
cose values from POC-GM should be used for treatment decisions, such as how much in-
sulin should be taken or should low blood glucose be treated by the consumption of extra 
carbohydrates. 
This study examines the impact of CGM on duration of periods spent in low interstitial glu-
cose range (< 70 mg/dl) as well as on the proportion of low blood glucose values measured 
by POC-GM and the time until detection of low blood glucose values by use of POC-GM.
A B S T R A C T
I N T R O D U C T I O N
This cross-over-study with two phases was conducted in an inpatient setting. The order of the 
study phases was randomized (see Figure 1). All participants wore the CGM device (DEX-
COM Seven Plus, Nintamed) twice. Sensors were deployed in the late morning or afternoon. 
41 diabetic patients took part in this study (for sample characteristics see Table 1). The mean 
time of CGM use during the CGM-open and CGM-blind phase was highly comparable (see Fi-
gure 2). Additionally, in both phases a highly comparable number of POC-GM measurements 
was found (see Figure 3). 
The system accuracy according to ISO 15197 is depicted in Figure 4. Approximately 70% of 
all pairs of CGM and POC-GM measurements fell within the range established by ISO 15197. 
There was no major difference between the CGM-open and CGM-blind phase. The overall 
Mean Absolute Relative Difference (MARD) was also comparable in both study phases. Inte-
restingly, in both study phases the MARD was significantly higher in the hypoglycemic range 
compared to the eu- or hyperglycemic glucose range (see Figure 5).
The overall mean glucose value was not affected by CGM use (see Figure 6 and 7). However, 
during the CGM-open phase the duration of hypoglycemic periods measured in the intersti-
tial fluid was significantly reduced and the duration of the euglycemic phase was significantly 
increased (see Figure 8). There was no impact on the duration of the hyperglycemic periods 
in the interstitial fluid. All significance tests were adjusted for order of study phase. No signi-
ficant order effects were observed.
The beneficial effects of open CGM on the shortening of hypoglycemic periods and the ex-
tension of euglycemic periods per day could also be demonstrated by using POC-GM measu-
rements. The proportion of blood glucose values in the hypoglycemic range could be signifi-
cantly reduced, whereas the proportion of euglycemic glucose readings could be significantly 
increased (see Figure 9). The time between the last euglycemic glucose measurement and 
the hypoglycemic blood glucose measurement could be significantly shortened by the use of 
CGM (see Figure 10 + 11).
These results demonstrate that CGM used for insulin doses and use of trend information and 
hypoglycemic alerts does not only diminish low interstitial glucose values, but also reduces 
the proportion of low blood glucose values measured by POC-GM. In addition, the time for 
the detection of a hypoglycemic episode by POC-GM was significantly shortened. Thus, the 
impact of CGM on decreasing the number of hypoglycemia could not only be demonstrated 
by CGM measurements itself but also by the use of a more precise POC-GM measurement 
as a reference method.
Figure 2:  Duration of CGM phases
Figure 8:  Duration of hypo-, eu- and hyperglycemic glucose phases measured by CGM
Figure 10: Box plot time until detection of 
hypoglycemia by POC
Figure 6:  Dot density plot of mean glucose 
values during CGM
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Figure 3:  Number of POC-GM measure-
ments
Figure 4:  System accuracy according to 
ISO 15197
Figure 5:  Mean absolute relative  
difference (MARD)
Figure 9:  Proportion of POC-GM blood glucose values in the hypo-, eu- and hyperglyce-
mic range
Figure 11: Duration till hypoglycemia detec-
tion by POC-GM
Figure 7:  Mean glucose in interstitial fluid
M E T H O D S
After a calibration period of 2 hours the active measurement phase started. The calibration 
was done by capillary blood glucose measurement using a POC - GM (Glucometer 3000, Bio 
Sensor Technology, Germany), which was subjected to laboratory quality control. In additi-
on, capillary blood glucose was measured routinely 6 times a day (fasting, post breakfast, 
pre-lunch, post lunch, pre-dinner and before bedtime) in both study phases.
In one phase (CGM-blind), participants wore the CGM device, but were blinded against the 
results. Also, no alerts were given when glucose values reached certain critical hypoglyce-
mic (< 80 mg/dl) or hyperglycemic (> 180 mg/dl) thresholds. In the other study phase (CGM-
open), CGM results and trend information were available for patients. If critical hypoglyce-
mic or hyperglycemic thresholds were exceeded an alert was given. Patients had to confirm 
possible hypo- or hyperglycemia by a capillary blood glucose measurement using POC-GM. 
Adjustments of insulin dose at mealtime could be based on CGM measurements if POC-GM 
measurement did deviate less than 20% from CGM measurement (checked by a medical 
staff).   
Outcome measures were the duration of periods with low interstitial glucose. In addition, it 
was analyzed if a beneficial impact of CGM on the avoidance of hypoglycemia could be de-
monstrated with POC-GM measurement (proportion of low blood glucose measurements) 
and if a low blood glucose value could be detected earlier by POC-GM measurement. Signi-
ficance tests were adjusted for order effects of the study phases.
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